Skip to main content

Advertisement

Log in

The Use of Daily and On-Demand Oral Pre-Exposure Prophylaxis Dosing Strategies Among Young Adult Gay, Bisexual and Other Men who have Sex with Men Enrolled in an mHealth Adherence Intervention

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention option for gay, bisexual and other men who have sex with men (GBMSM). However, with newer PrEP options, a greater understanding of whether and why GBMSM switch dosing strategies is needed to inform clinical practice and research. We assessed the dosing strategies (daily or on-demand) of GBMSM enrolled in an mHealth PrEP adherence pilot intervention at four timepoints over approximately 10 months. Among GBMSM with complete data (n = 66), a consistent daily dosing strategy was used by most (73%) participants across all time points, while on-demand PrEP was used at least once during the study period by 27% of participants. A higher percentage of on-demand PrEP users self-reported as Asian/Pacific Islander and had less positive attitudes toward PrEP, adjusting for key sociodemographic variables and intervention arm. Daily PrEP users reported high numbers of sexual partners, and the primary reason that they would switch to on-demand PrEP is reduced sexual activity. At the final assessment, 75% of participants were taking daily PrEP, of whom 27% reported that they would like to switch to another option, including on-demand and long-acting injectable PrEP. While findings were largely descriptive, they showed that switches in PrEP dosing strategies are relatively common and PrEP strategy choice may vary across racial and ethnic groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men who have sex with men. N Engl J Med. 2010;363(27):2587–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and Pre-Exposure Prophylaxis Efficacy in Men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.

    Article  Google Scholar 

  3. Centers for Disease Control and Prevention. HIV and Gay and Bisexual Men 2021 [Available from: https://www.cdc.gov/hiv/group/msm/index.html].

  4. Whitfield THF, Parsons JT, Rendina HJ. Rates of pre-exposure Prophylaxis Use and Discontinuation among a large U.S. National Sample of sexual minority men and adolescents. Arch Sex Behav. 2020;49(1):103–12.

    Article  PubMed  Google Scholar 

  5. Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the motivational PrEP cascade. J Acquir Immune Defic Syndr. 2017;74(3):285.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): HIV diagnoses and linkage to HIV medical care, 2019 and 2020 (reported through September 2020); and preexposure prophylaxis (PrEP), 2018 (updated), 2019 and 2020 (reported through June 2020). 2021 [Available from: http://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-1-no-7/index.html.

  7. Centers for Disease Control and Prevention. PrEP for HIV Prevention in the U.S. 2021 [Available from: https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html.

  8. Spinelli MA, Grinsztejn B, Landovitz RJ. Promises and challenges: cabotegravir for preexposure prophylaxis. Curr Opin HIV AIDS. 2022;17(4):186–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Schmidt H-MA, Rodolph M, Schaefer R, Baggaley R, Doherty M. Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice. J Int AIDS Soc. 2022;25(7):e25963.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and Prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel. JAMA. 2020;324(16):1651–69.

    Article  CAS  PubMed  Google Scholar 

  11. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand preexposure Prophylaxis in Men at High Risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.

    Article  CAS  PubMed  Google Scholar 

  12. Beymer MR, Gildner JL, Holloway IW, Landovitz RJ. Acceptability of Injectable and On-Demand pre-exposure Prophylaxis among an online sample of Young Men who have sex with men in California. LGBT Health. 2018;5(6):341–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Mansergh G, Kota KK, Stephenson R, Hirshfield S, Sullivan P. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities. J Int AIDS Soc. 2021;24(1):e25664.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Carneiro PB, Rincon C, Golub S. Predictors of event-driven regimen choice in current PrEP users and sexual behavior characteristics of MSM receiving sexual Health Services in New York City. AIDS Behav. 2021;25(8):2410–8.

    Article  PubMed  Google Scholar 

  15. Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, et al. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. J Int AIDS Soc. 2019;22(10):e25407.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, van der Schim MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447–e55.

    Article  PubMed  Google Scholar 

  17. Coyer L, van den Elshout MAM, Achterbergh RCA, Matser A, van der Schim MF, Davidovich U et al. Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men. EClinicalMedicine. 2020;29–30:100650.

  18. Hoornenborg E, Achterbergh RC, van der Loeff MFS, Davidovich U, van der Helm JJ, Hogewoning A, et al. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam. J Int AIDS Soc. 2018;21(3):e25105.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hojilla JC, Marcus JL, Silverberg MJ, Hare CB, Herbers R, Hurley L, et al. Early adopters of event-driven human immunodeficiency Virus Pre-exposure Prophylaxis in a large Healthcare System in San Francisco. Clin Infect Dis. 2020;71(10):2710–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Cornelisse VJ, Lal L, Price B, Ryan KE, Bell C, Owen L, et al. Interest in switching to On-Demand HIV Pre-Exposure Prophylaxis (PrEP) among australian users of Daily PrEP: an online survey. Open Forum Infect Dis. 2019;6(7):ofz287.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Vaccher SJ, Gianacas C, Templeton DJ, Poynten IM, Haire BG, Ooi C, et al. Baseline preferences for Daily, Event-Driven, or periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE demonstration project. Front Public Health. 2017;5:341.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Chan C, Vaccher S, Fraser D, Grulich AE, Holt M, Zablotska-Manos I, et al. Preferences for current and future PrEP modalities among PrEP-Experienced gay and bisexual men in Australia. AIDS Behav. 2022;26(1):88–95.

    Article  PubMed  Google Scholar 

  23. Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. [References] Health Psychol. 1994;13(3):238–50.

    Article  CAS  Google Scholar 

  24. Fisher J, Fisher W, Bryan A, Misovich S. Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychol. 2002;21(2):177–86.

    Article  PubMed  Google Scholar 

  25. Fisher WA, Fisher JD, Harman J. The information-motivation-behavioraI skills model: A general social psychological approach to understanding and promoting health behavior. [References]: Suls, Jerry, editor; Wallston, Kenneth A, editor. (2003). Social psychological foundations of health and illness. (pp. 82–106). xx, 583 pp. Malden, MA, US: Blackwell Publishing.; 2003.

  26. Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and Individual Associations with PrEP Stigma: results from the RADAR Cohort of Diverse Young Men who have sex with men and Transgender Women. AIDS Behav. 2018;22(9):3044–56.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Crepaz N, Mullins MM, Higa D, Gunn JKL, Salabarría-Peña Y. A Rapid Review of Disparities in HIV Prevention and Care Outcomes among Hispanic/Latino men who have sex with men in the United States. AIDS Educ Prev. 2021;33(4):276–89.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015–2019. HIV Surveillance Supplemental Report. 2021;26 (1).

  29. Flores DD, Meanley SP, Wood SM, Bauermeister JA. Family characteristics in Sex Communication and Social Support: implications for emerging adult men who have sex with Men’s PrEP Engagement. Arch Sex Behav. 2020;49(6):2145–53.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Dunville R, Harper C, Johns MM, Heim Viox M, Avripas S, Fordyce E, et al. Awareness and willingness to Use Biomedical Prevention Strategies for HIV among sexual and gender minority youth: results from a National Survey. J Adolesc Health. 2021;68(1):199–206.

    Article  PubMed  Google Scholar 

  31. Biello KB, Hosek S, Drucker MT, Belzer M, Mimiaga MJ, Marrow E, et al. Preferences for Injectable PrEP among Young U.S. Cisgender Men and Transgender Women and Men who have sex with men. Arch Sex Behav. 2018;47(7):2101–7.

    Article  PubMed  Google Scholar 

  32. Rowe K, Theodore DA, Zucker J, Cohensedgh O, LaSota E, Carnevale C, et al. Lost2PrEP: understanding reasons for pre-exposure prophylaxis and sexual Health Care Disengagement among Men who have sex with men attending a sexual health clinic at a large Urban Academic Medical Center in New York City. AIDS Patient Care STDS. 2022;36(4):153–8.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Volk JE, Liu A, Vittinghoff E, Irvin R, Kroboth E, Krakower D, et al. Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2012;61(1):112–5.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wu HJ, Yu YF, Ku SW, Tseng YC, Yuan CW, Li CW, et al. Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in Taiwan. Digit Health. 2022;8:20552076221102770.

    PubMed  PubMed Central  Google Scholar 

  35. Strong C, Wu HJ, Tseng YC, Yuan CW, Yu YF, Liao JC, et al. Mobile App (UPrEPU) to monitor adherence to pre-exposure Prophylaxis in Men who have sex with men: protocol for a user-centered Approach to Mobile App Design and Development. JMIR Res Protoc. 2020;9(12):e20360.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Serota DP, Rosenberg ES, Sullivan PS, Thorne AL, Rolle CM, Del Rio C, et al. Pre-exposure Prophylaxis Uptake and Discontinuation among Young Black Men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis. 2020;71(3):574–82.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the participants for their time and contributions to this study. This project is supported by a grant from the National Institute of Mental Health (NIMH), awarded to Drs. Keith J. Horvath and Jason V. Baker; R34MH116878.

Funding

This project is supported by a grant from the National Institute of Mental Health (NIMH), awarded to Drs. Keith J. Horvath and Jason V. Baker; R34MH116878.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keith J. Horvath.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest relevant to this article to disclose.

Ethics Approval

This study (HS-2019-0291) was approved by San Diego State University Institutional Review Board.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horvath, K.J., Ma, J., Storholm, E.D. et al. The Use of Daily and On-Demand Oral Pre-Exposure Prophylaxis Dosing Strategies Among Young Adult Gay, Bisexual and Other Men who have Sex with Men Enrolled in an mHealth Adherence Intervention. AIDS Behav 27, 3632–3644 (2023). https://doi.org/10.1007/s10461-023-04077-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-023-04077-1

Keywords

Navigation